News
TrialHub celebrates five years of increasing access to trials for underserved populations including individuals diagnosed with melanoma, rare cancers and those living in outer metropolitan, regional, rural and remote areas.
We are proud to announce the successful completion of 24-months of follow-up for the IMAGE trial, a landmark study evaluating the role of Melanoma Surveillance Photography (MSP) in improving early detection of melanoma among high and ultra-high-risk patients.
Leading skin care brand Avène has raised nearly $39,000 to support clinical trials led by Melanoma and Skin Cancer Trials.
The Australasian Ocular Melanoma Alliance (AOMA) held an educational gathering in Hobart on the 7th of March.
Led by MASC Trials and Dr Malaka Ameratunga, the BETTER trial aims to improve the care, treatment and quality of life for symptomatic patients with melanoma that has spread to the brain.
To help conquer the urgent problem Australia has with melanoma and skin cancer, leading skin care brand Avène has teamed up with Melanoma and Skin Cancer Trials.
The incredible efforts of the team behind Conquering Skin Cancer were recognised at the 2025 Impact DOCS Awards with Awards of Excellence for Best Documentary Feature and Best Direction. There are also new screening locations and sessions to be held in in South Australia and New South Wales.
Melanoma and Skin Cancer Trials has been chosen by the Australian Livestock and Property Agents Association (ALPA) as its 2024 charity.
As a young doctor, Prof Mark Shackleton was focused on becoming a neurologist, until one day, he found himself on an oncology ward. Witnessing the profound challenges faced by cancer patients left a deep impact on him, igniting a passion for melanoma research.
Melanoma and Skin Cancer Trials and the Victorian Heart Institute are leading an Australian-first trial to determine if a common cholesterol medication can reduce the risk of heart attacks in melanoma patients treated with cancer therapy.